DK2436765T3 - Rekombinant faktor X uden glycosylering og fremgangsmåde til fremstilling deraf - Google Patents

Rekombinant faktor X uden glycosylering og fremgangsmåde til fremstilling deraf

Info

Publication number
DK2436765T3
DK2436765T3 DK11190376.1T DK11190376T DK2436765T3 DK 2436765 T3 DK2436765 T3 DK 2436765T3 DK 11190376 T DK11190376 T DK 11190376T DK 2436765 T3 DK2436765 T3 DK 2436765T3
Authority
DK
Denmark
Prior art keywords
glycosylation
preparation
recombinant factor
recombinant
factor
Prior art date
Application number
DK11190376.1T
Other languages
English (en)
Inventor
Kenji Soejima
Takayuki Imamura
Ryoichi Kawamura
Hiroshi Nakatake
Arisa Maeyashiki
Hitomi Togo
Original Assignee
Chemo Sero Therapeut Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeut Res Inst filed Critical Chemo Sero Therapeut Res Inst
Application granted granted Critical
Publication of DK2436765T3 publication Critical patent/DK2436765T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6432—Coagulation factor Xa (3.4.21.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21006—Coagulation factor Xa (3.4.21.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK11190376.1T 2007-10-09 2008-10-08 Rekombinant faktor X uden glycosylering og fremgangsmåde til fremstilling deraf DK2436765T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007263640 2007-10-09
EP08837781A EP2202306B1 (en) 2007-10-09 2008-10-08 Recombinant factor x with no glycosylation and method for preparing the same

Publications (1)

Publication Number Publication Date
DK2436765T3 true DK2436765T3 (da) 2014-01-13

Family

ID=40549211

Family Applications (2)

Application Number Title Priority Date Filing Date
DK08837781.7T DK2202306T3 (da) 2007-10-09 2008-10-08 Rekombinant faktor x uden glycosylering og fremgangsmåde til fremstilling deraf
DK11190376.1T DK2436765T3 (da) 2007-10-09 2008-10-08 Rekombinant faktor X uden glycosylering og fremgangsmåde til fremstilling deraf

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK08837781.7T DK2202306T3 (da) 2007-10-09 2008-10-08 Rekombinant faktor x uden glycosylering og fremgangsmåde til fremstilling deraf

Country Status (5)

Country Link
US (3) US8173777B2 (da)
EP (2) EP2202306B1 (da)
JP (1) JP5513120B2 (da)
DK (2) DK2202306T3 (da)
WO (1) WO2009048067A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009048067A1 (ja) * 2007-10-09 2009-04-16 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute 糖鎖を持たない遺伝子組換え血液凝固第x因子およびその製法
KR20120045218A (ko) * 2010-10-29 2012-05-09 삼성전자주식회사 멀티 터치를 이용한 문자 입력 방법 및 장치
WO2014008172A2 (en) * 2012-07-03 2014-01-09 Expression Therapeutics, Llc High yield suspension cell line, system and method for making same
MX365612B (es) 2012-07-25 2019-06-07 Catalyst Biosciences Inc Polipeptidos de factor x modificados y usos de los mismos.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2824434B2 (ja) 1989-11-28 1998-11-11 財団法人化学及血清療法研究所 新規発現ベクター
US20040072757A1 (en) * 1990-09-04 2004-04-15 Cor Therapeutics, Inc. Agents affecting thrombosis and hemostasis
US5278144A (en) * 1990-09-04 1994-01-11 Cor Therapeutics, Inc. Antithrombosis agents
JPH07507769A (ja) * 1992-03-20 1995-08-31 コアー・セラピュティックス・インコーポレーテッド Ｘ因子のグリコシル化媒介による阻害
EP1379667A2 (en) * 2000-12-05 2004-01-14 The Penn State Research Foundation Methods and compositions for highly efficient production of heterologous proteins in yeast
JP2006280253A (ja) * 2005-03-31 2006-10-19 Yamaguchi Univ 耐熱性酵素を高生産できる酵母変異株
EP1728798A1 (en) * 2005-06-01 2006-12-06 ZLB Behring GmbH Coagulation factor X polypeptides with modified activation properties
WO2009048067A1 (ja) * 2007-10-09 2009-04-16 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute 糖鎖を持たない遺伝子組換え血液凝固第x因子およびその製法

Also Published As

Publication number Publication date
EP2436765A2 (en) 2012-04-04
EP2436765A3 (en) 2012-05-09
JP5513120B2 (ja) 2014-06-04
US20120231523A1 (en) 2012-09-13
JPWO2009048067A1 (ja) 2011-02-17
US20100285568A1 (en) 2010-11-11
DK2202306T3 (da) 2013-01-21
EP2202306A4 (en) 2011-03-30
WO2009048067A1 (ja) 2009-04-16
US8679783B2 (en) 2014-03-25
US8293874B2 (en) 2012-10-23
EP2202306B1 (en) 2012-12-19
EP2202306A1 (en) 2010-06-30
EP2436765B1 (en) 2013-12-11
US20120039863A1 (en) 2012-02-16
US8173777B2 (en) 2012-05-08

Similar Documents

Publication Publication Date Title
DK1973429T3 (da) Proteinhydrolysater og fremgangsmåde til fremstilling
DK3281947T3 (da) Sammensætninger og fremgangsmåder relateret til protein A (SPA)-varianter
DK3156075T3 (da) Oligosaccharid og fremgangsmåde til fremstilling deraf
IL205253A0 (en) Tubulysins and processes for preparing
EP2298801A4 (en) GLYCOSYLATED GLP-1 PEPTIDE
DK3067064T3 (da) Modificerede rsv-f-proteiner og fremgangsmåder til anvendelse deraf
IL215480A0 (en) Control of protein glycosylation and compositions and methods relating thereto
DK3263100T3 (da) L-ornithinphenylacetat og fremgangsmåder til fremstilling deraf
BRPI0916515A2 (pt) polipeptídeo de g-csf bovinos modificados e usos dos mesmos
DK2358669T3 (da) Alpha-keto-persyrer og fremgangsmåder til fremstilling og anvendelse heraf
DK2352509T3 (da) Hla-g-proteiner og farmaceutiske anvendelser deraf
DK2029799T3 (da) Termostabile proteiner og fremgangsmåder til fremstilling og anvendelse heraf
DK2805746T3 (da) Alkylamido-forbindelser og anvendelser deraf
GB0915403D0 (en) Protein glycosylation
DK2475649T3 (da) Indenonderivat og farmaceutisk sammensætning omfattende samme
IL219289A0 (en) Antibody glycosylation variants
DK2114393T3 (da) Farmaceutiske sammensætninger omfattende trigonellin og 4-hydroxyisoleucin og fremgangsmåde hertil
DK3342292T3 (da) Fast mælk og fremgangsmåde til fremstilling deraf
SG10201507362TA (en) Novel Regulatory Proteins And Inhibitors
DK2666854T3 (da) Rekombinante elastase-proteiner og fremgangsmåder til fremstilling og anvendelse deraf
DK2190665T3 (da) Kompositorgan og fremgangsmåde til dets fremstilling
EP2189476A4 (en) NOVEL POLYPEPTIDE AND MANUFACTURING METHOD THEREFOR
HRP20150620T1 (en) A polypeptide for use in treating dengue virus infections
DK2131682T3 (da) Autoklave og fremgangsmåde
DK1999403T3 (da) Multikoblingssystem og fremgangsmåde relateret dertil